| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |